In the pioneer work by Sørlie and Perou, five intrinsic subtypes were identified, luminal A, luminal B, basal-like, HER2-enriched, and normal-like, that largely reflected the clinical classification of breast cancer subtypes based on the expression of hormone receptors, HER2, and Ki67 (46, 47). This evidence concerns the gene ERBB2 and breast carcinoma.